Details for New Drug Application (NDA): 206234
✉ Email this page to a colleague
The generic ingredient in SEVELAMER CARBONATE is sevelamer carbonate. There are thirty-two drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the sevelamer carbonate profile page.
Summary for 206234
Tradename: | SEVELAMER CARBONATE |
Applicant: | Invagen Pharms |
Ingredient: | sevelamer carbonate |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | FOR SUSPENSION;ORAL | Strength | 800MG/PACKET | ||||
Approval Date: | Jul 12, 2024 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | FOR SUSPENSION;ORAL | Strength | 2.4GM/PACKET | ||||
Approval Date: | Jul 12, 2024 | TE: | AB | RLD: | No |
Complete Access Available with Subscription